Recurrent ovarian cancer
نویسندگان
چکیده
منابع مشابه
Treatment of recurrent ovarian cancer.
Recurrent ovarian cancer is a common clinical problem and the management of each patient must be individualized. Diagnosis is usually based on a progressively rising CA-125 titre, and a CT scan of the pelvis and abdomen, together with a chest X-ray should be performed in this situation. Although there is no study to support immediate treatment in the asymptomatic patient, our approach is to com...
متن کاملBayesian Decision Analysis for Recurrent Ovarian Cancer
All cancers are usually classified further according to the extent or stage of disease so that therapies may be tailored to the particular disease stage. Moreover, detection of asymptomatic recurrences is associated with prolonged overall survival and survival from the time of initial detection of recurrence. This study applied Bayesian decision theorem to an inferential problem of recurrent ov...
متن کاملTreatment of recurrent epithelial ovarian cancer
Epidemiologic analysis reveals that the mortality rate from ovarian cancer is continuously decreasing due to the improvement of surgery and chemotherapy. However, the prognosis of ovarian cancer patients is still unsatisfactory overall considering that only 30% of patients are alive after five years. In fact, although surgery and first-line systemic chemotherapy induces complete and partial res...
متن کاملManagement of Recurrent or Persistent Ovarian Cancer
Approximately 70-80% of patients with epithelial ovarian cancer will relapse after first-line chemotherapy with a platinum and taxane-based combination. These patients require further treatment and they may benefit from local and/or systemic therapy. The prognosis is poor and the management of relapsed ovarian cancer remains a difficult problem open to research [National Cancer Institute (NCI),...
متن کاملCarbon beam therapy in recurrent ovarian cancer.
Ovarian cancer results in more deaths than any other gynecologic malignancy. In the United States and Japan, there are >15 000 and 4000 deaths from ovarian cancer per year, respectively [1]. This high mortality rate can be attributed to 75% of patients who are diagnosed with stage III and IV disease with i.p. carcinomatosis [2]. Although the 5-year survival rate of patients in whom lymph nodes ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2016
ISSN: 0923-7534
DOI: 10.1093/annonc/mdw079